Steadymed Stock Price, News & Analysis

STDY

Company Description

Steadymed (Nasdaq: STDY) is a publicly traded company.

STDY stock has gained 0.0% over the past year.

This page provides a comprehensive overview of STDY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

26.7M

Shares outstanding

Latest News

View All

June 20, 2024

0.00%

Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer

management

Steadymed has 1 recent news article. Key topics include management. View all STDY news →

SEC Filings

View All

No SEC filings available for STDY.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months